St. Jude, iRhythm to co-market cardiac rhythm monitor
St. Jude Medical and iRhythm Technologies have entered into an agreement to market iRhythm’s Zio Patch, a single-use ambulatory cardiac rhythm monitor that recently received FDA 510k clearance.
San Francisco-based iRhythm also closed a $10 million private equity round of financing, led by St. Jude, including investors Mohr Davidow Ventures and Synergy Life Science Partners. The profits of the deal will be used to launch the Zio Patch.
The co-marketing partnership will also include iRhythm’s cardiac rhythm event monitor, the Zio event card, according to St. Paul, Minn.-based St. Jude.
San Francisco-based iRhythm also closed a $10 million private equity round of financing, led by St. Jude, including investors Mohr Davidow Ventures and Synergy Life Science Partners. The profits of the deal will be used to launch the Zio Patch.
The co-marketing partnership will also include iRhythm’s cardiac rhythm event monitor, the Zio event card, according to St. Paul, Minn.-based St. Jude.